| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Nuclear Medicine |
1 From the Departments of Radiology (B.F.B., T.M.B., S.R., C.C.M.), Otolaryngology (B.F.B., L.A.Z., C.H.S., J.T.J.), Neurology (C.C.M.), and Psychiatry (C.C.M.), University of Pittsburgh School of Medicine, 200 Lothrop St, PUH Rm D-132, Pittsburgh, PA 15213. Received January 23, 2004; revision requested April 2; final revision received October 4; accepted October 12. Address correspondence to B.F.B. (e-mail: bfb1@pitt.edu).
PURPOSE: To prospectively determine whether combined positron emission tomography (PET) and computed tomography (CT) is more accurate than either PET or CT alone in depicting malignant lesions in the head and neck.
MATERIALS AND METHODS: Study was approved by the institutional review board, and patient informed consent was waived. Sixty-five consecutive patients (42 men, 23 women; age range, 43–83 years) known to have or suspected of having head and neck cancer were examined with combined PET/CT. CT was performed with intravenous administration of a contrast agent, and the CT data were used for attenuation correction. Each examination was interpreted in three ways: PET images in the absence of CT data, CT images in the absence of PET data, and fused PET/CT images. Probability of malignancy of each lesion was assigned a score by using a five-point scale. Receiver operating characteristic (ROC) analyses were performed by using biopsy, imaging, or clinical follow-up as the reference standard. The minimum follow-up was 6 months (range, 6–12 months). The results were additionally analyzed to assess the degree of radiologist confidence.
RESULTS: Follow-up was available for 64 (98%) of 65 patients. ROC analyses demonstrated that PET/CT is significantly superior to PET or CT alone for depiction of malignancy in the head and neck (P < .05). In this series, PET/CT had a sensitivity of 98%, a specificity of 92%, and an accuracy of 94%. Radiologist confidence was substantially higher with the combined modality.
CONCLUSION: Combined PET/CT is more accurate than PET or CT alone for the depiction of malignancy in the head and neck. Radiologist confidence is improved with the combined modality.
© RSNA, 2005
This article has been cited by other articles:
|
|
 |
|
  A. M. Scott, D. H. Gunawardana, D. Bartholomeusz, J. E. Ramshaw, and P. Lin PET Changes Management and Improves Prognostic Stratification in Patients with Head and Neck Cancer: Results of a Multicenter Prospective Study J. Nucl. Med., October 1, 2008; 49(10): 1593 - 1600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Comoretto, L. Balestreri, E. Borsatti, M. Cimitan, G. Franchin, and M. Lise Detection and Restaging of Residual and/or Recurrent Nasopharyngeal Carcinoma after Chemotherapy and Radiation Therapy: Comparison of MR Imaging and FDG PET/CT Radiology, October 1, 2008; 249(1): 203 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y-H CHEN, J J-M JIAN, K-Y CHAN, S Y TSAI, S H CHENG, K-C L YEN, and J C-H CHENG Definitive chemoirradiation for resectable head and neck cancer: treatment outcome and prognostic significance of MRI findings Br. J. Radiol., June 1, 2008; 81(966): 490 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Boughanim, S. Leboulleux, A. Rey, C. Tuan Pham, Y. Zafrani, P. Duvillard, J. Lumbroso, C. Haie-Meder, M. Schlumberger, and P. Morice Histologic Results of Para-Aortic Lymphadenectomy in Patients Treated for Stage IB2/II Cervical Cancer With Negative [18F]Fluorodeoxyglucose Positron Emission Tomography Scans in the Para-Aortic Area J. Clin. Oncol., May 20, 2008; 26(15): 2558 - 2561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Ong, H. Schoder, N. Y. Lee, S. G. Patel, D. Carlson, M. Fury, D. G. Pfister, J. P. Shah, S. M. Larson, and D. H. Kraus Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer J. Nucl. Med., April 1, 2008; 49(4): 532 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Fletcher, B. Djulbegovic, H. P. Soares, B. A. Siegel, V. J. Lowe, G. H. Lyman, R. E. Coleman, R. Wahl, J. C. Paschold, N. Avril, et al. Recommendations on the Use of 18F-FDG PET in Oncology J. Nucl. Med., March 1, 2008; 49(3): 480 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. N. Shah and B. F. Branstetter IV Oncocytoma of the Parotid Gland: A Potential False-Positive Finding on 18F-FDG PET Am. J. Roentgenol., October 1, 2007; 189(4): W212 - W214. [Full Text] [PDF]
|
|
|
|
|
|
A. Shammas, B. Degirmenci, J. M. Mountz, B. M. McCook, B. Branstetter, B. B. Bencherif, J. M. Joyce, S. E. Carty, H. A. Kuffner, and N. Avril 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic Well-Differentiated Thyroid Cancer J. Nucl. Med., February 1, 2007; 48(2): 221 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Czernin, M. Allen-Auerbach, and H. R. Schelbert Improvements in Cancer Staging with PET/CT: Literature-Based Evidence as of September 2006 J. Nucl. Med., January 1, 2007; 48(1_suppl): 78S - 88S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Berry and G. J. R. Cook Positron emission tomography in oncology Br. Med. Bull., December 14, 2006; (2006) ldl013v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Branstetter IV Physiologic 18F-FDG uptake in the serratus anterior muscle: a potential false-positive on PET resolved with PET/CT. Am. J. Roentgenol., August 1, 2006; 187(2): W235 - W235. [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Mukherji and C. R. Bradford Controversies: Is There a Role for Positron-Emission Tomographic CT in the Initial Staging of Head and Neck Squamous Cell Carcinoma? AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 243 - 245. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
